Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 I, 2000, Pages 1377-1382

  Khan, L N ^a   Onn Min Kon, ^a   Macfarlane, A J ^a   Meng, Q ^a   Ying, S ^a   Barnes, N C ^a   Kay, A B ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA CHEMOKINE; CYCLOSPORIN A; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; PLACEBO;

ADULT; ALLERGIC ASTHMA; ARTICLE; BASOPHIL; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033773992     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.4.9911117     Document Type: Article

References (35)

1. Trial of cyclosporin A in corticosteroid-dependent chronic severe asthma
2. Double blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
3. Effect of cyclosporin A on the allergen-induced late asthmatic reaction
4. Bronchial provocation tests in etiologic diagnosis and analysis of asthma
5. The appearance of hypodense eosinophils in antigen-dependent late-phase asthma
6. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in atopic asthmatics
7. Increases in activated T lymphocytes, eosinophils and cytokine messenger RNA for IL-5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
8. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma
9. Increases in eotaxin positive cells in induced sputum from atopic asthmatic subjects following inhalational allergen challenge
10. Heterogeneity of human peripheral blood eosinophil-type colonies: Evidence for a common basophil-eosinophil progenitor
11. High expression of the chemokine receptor CCR3 in human blood basophils
12. IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor α-subunit and common β-subunit expression by peripheral leukocytes and blood dendritic cells
13. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1
14. Standardisation of bronchial challenge procedures
15. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells
16. Basophils, eosinophils and mast cells in atopic and non-atopic asthma and in late-phase allergic reactions in the lung and skin
17. Enhanced detection of interleukin-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes
18. IgE-independent MHC-restricted T cell peptide epitope-induced late asthmatic reactions
19. Recombinant human interleukin 5 is a selective activator of human eosinophil function
20. Cloning of the human eosinophil chemoattractant, eotaxin: Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
21. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, MCP-3 MCP-4) and CCR3 expression in bronchial biopsies from atopic and non-atopic (intrinsic) asthmatics
22. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and eotaxin-2 and MCP-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (MCP-3 and RANTES)
23. Inhibition of antigen-induced late asthmatic response and bronchial hyperresponsiveness by cyclosporin and FK 506
24. Effect of inhaled cyclosporin A on the allergen-induced late asthmatic response and increased in airway hyperresponsiveness in a guinea pig model of asthma
25. Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs
26. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats
27. 4
28. Cyclosporin A treatment and airways inflammation in corticosteroid-dependent asthma
29. Clinical response to cyclosporine therapy in chronic severe asthma is associated with a reduction in serum concentrations of soluble interleukin-2 receptor
30. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A
31. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma
32. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils and mast cells in bronchial biopsies obtained from atopic and non-atopic (intrinsic) asthmatics
33. In vivo characterisation of the anti-inflammatory effect of cyclosporin A on human basophils
34. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and survival
35. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol